서브이미지

R&D

HealthBiome is going to contribute to the promotion of human
health through continuous research and development
HealthBiome is going to contribute
to the promotion of human health through
continuous research and development

About Lab
From healthy gut to healthy body,
our health exists in our body
HealthBiome’s research lab is studying the separation of human gut strict anaerobic microbial strains with excellent efficacy in treating cancer, brain nervous, ageing diseases, and is also developing microbiome-based disease treatment substances. The research lab has been expanding the scope of application to not only new drugs for disease treatment, but also preventive functional foods, medical foods, cosmetics, animal medicines and health functional feed.
Global development status of microbiome treatments

Pre-clinical phase indications

Neurological disorders
  • Depression
  • Autism
  • Alzheimer’s disease
  • Multiple sclerosis
Cardiovascular disease
  • Hypertension
Inflammation
  • Rheumatoid arthritis

IND phase indications

Metabolic disorders
  • Obesity
Cancer
  • Immuno-oncology
  • Chemotherapy
  • Combination therapy

Clinical phase indications

Gastro-intestinal disorders
  • Crohn’s disease
  • Ulcerative colitis
Infectious diseases
  • Clostridium difficile infection
  • Dental carries
  • Bacterial vaginosis
Metabolic disorders
  • Diabetes
Skin disorders
Rare diseases
  • Hyperoxaluria
  • Urea cycle disorder
  • Phenylketonuria